FDA official logo
GSRS logo
PFDA official logo

SPARTALIZUMAB

  • UNII: QOG25L6Z8Z
  • Preferred Substance Name: SPARTALIZUMAB

  • 1935694-88-4
  • ANTI-PD1 MONOCLONAL ANTIBODY PDR001
  • IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1)(HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS240118 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS240118 .KAPPA.-CHAIN, DIMER
  • NVP-LZV184
  • PDR001
  • PDR-001
  • SPARTALIZUMAB [INN]
  • SPARTALIZUMAB [JAN]
  • SPARTALIZUMAB [USAN]
  • SPARTALIZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.